1 / 33

Healthy People 2010 targets & levels achieved in 2000 figure hp.1

This report examines trends in End-Stage Renal Disease (ESRD) incident rates, cardiovascular mortality rates, and preventive health measures in dialysis patients. The data includes rates per million population, adjusted for age, gender, and race/ethnicity.

pmcnair
Télécharger la présentation

Healthy People 2010 targets & levels achieved in 2000 figure hp.1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Healthy People 2010 targets & levels achieved in 2000figure hp.1

  2. Trends in ESRD incident ratesfigure hp.2, incident ESRD patients, adjusted for age, gender, & race

  3. ESRD incident rates, by year table hp.a, rate per million population, incident ESRD patients

  4. Trends in ESRD incident ratesfigure hp.3, incident ESRD patients, by age & race/ethnicity

  5. Trends in ESRD incident rates, by primary diagnosis, & in rates of diabetes in the general population figure hp.4, adjusted for age, gender, & race

  6. Trends in cardiovascular mortality rates among ESRD patients figure hp.5, period prevalent patients

  7. Cardiovascular mortality rates in ESRD patients, by modality table hp.b, deaths per 1,000 patient years at risk, period prevalent ESRD patients

  8. Trends in all-cause & cardiovascular mortality rates in ESRD patientsfigure hp.6, period prevalent ESRD patients, by race/ethnicity illi illi lla lla

  9. Trends in rates of cardiovascular disease in ESRD patientsfigure hp.7, deaths per 1,000 patient years, period prevalent ESRD patients illi illi lla lla

  10. Trends in arteriovenous fistula use in hemodialysis patients, by data source figure hp.8, incident hemodialysis patients, 1998-1999 combined Symbols D% from previous year illi illi lla lla

  11. Arteriovenous fistula use in incident hemodialysis patients, by data sourcetable hp.c, percent of patients illi illi lla lla

  12. Trends in arteriovenous fistula use in prevalent hemodialysis patients, by age & race/ethnicityfigure hp.9, period prevalent hemodialysis patients illi illi lla lla

  13. Trends in access fistula use in prevalent hemodialysis pts, by gender & diabetic statusfigure hp.10, period prevalent hemodialysis patients illi illi lla lla

  14. Trends in the percent of ESRD patients receiving influenza vaccinationsfigure hp.11 illi illi lla lla

  15. Percent of ESRD patients receiving influenza & pneumonia vaccinations, by yeartable hp.d, percent of patients vaccinated illi illi lla lla

  16. Trends in the percent of ESRD patients receiving influenza vaccinations, by age & race/ethnicity figure hp.12 illi illi lla lla

  17. Pneumococcal pneumonia vaccinations in ESRD patients, by age & race/ethnicityfigure hp.13, for 1995-1996 period illi illi lla lla

  18. Trends in the percent of dialysis patients on the transplant waiting listfigure hp.14, period prevalent hemodialysis patients illi illi lla lla

  19. Percent of patients on the transplant waiting list, by yeartable hp.e illi illi lla lla

  20. Dialysis pts on the transplant waiting list, by age, gender, race/ethnicity, & primary diagnosistable hp.15 illi illi lla lla

  21. Dialysis pts on the transplant waiting list, by age, gender, race/ethnicity, & primary diagnosistable hp.15 (cont.) illi illi lla lla

  22. Percent of dialysis patients receiving a transplant within 3 years of initiation of therapyfigure hp.16 illi illi lla lla

  23. Percent of dialysis patients receiving a transplant within 3 years of initiation, by yeartable hp.f illi illi lla lla

  24. Dialysis patients receiving a tx within 3 years, by age, gender, race/ethnicity, & diagnosisfigure hp.17 illi illi lla lla

  25. Dialysis patients receiving a tx within 3 years, by age, gender, race/ethnicity, & diagnosisfigure hp.17 (cont.) illi illi lla lla

  26. Trends in incident rates of ESRD due to diabetesfigure hp.18, incident ESRD patients, adjusted for age, gender, & race Bars: Rat per million population illi illi lla lla

  27. Incident rates of ESRD due to diabetes, by modality & yeartable hp.g, rate per million population, incident ESRD patients illi illi lla lla

  28. Trends in incident rates of ESRD due to diabetes, by agefigure hp.19, incident ESRD patients, adjusted for gender & race illi illi lla lla

  29. Trends in incident rates of ESRD due to diabetes, by race/ethnicityfigure hp.20, incident ESRD patients, adjusted for age & gender illi illi lla lla

  30. Percent of diabetic patients receiving all 3 diabetic preventive health tests, by data sourcefigure hp.21 General Medicare Pre-ESRD illi illi lla lla

  31. Percent of diabetic patients receiving preventive health tests, by test typetable hp.h, 1997-1999 illi illi lla lla

  32. Diabetics receiving all 3 preventive health tests, by pt population, age, & race/ethnicityfigure hp.22 illi illi lla lla

  33. Diabetics receiving all 3 preventive health tests, by pt population, age, & race/ethnicityfigure hp.22 (cont.) illi illi lla lla

More Related